Improving Preterm Kidney Outcomes With Caffeine

Abroad (travel likely)RecruitingPHASE2

Conditions

Kidney Injury · Pre-Term

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

UW Hospital and Clinics, Madison, Wisconsin, United States

Study leads

Matthew W Harer, MD
Principal Investigator
UW School of Medicine and Public Health

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patients Undergoing Debulking Surgery With Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Cisplatin.

Debulking Surgery for Ovarian Cancer · Acute Kidney Injury

Abroad (travel likely)RecruitingPHASE2

Madrid, Spain

Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients

Acute Kidney Injury · Fluid Overload · Fluid Overload in Dialysis Patients

Abroad (travel likely)Recruiting

Salvador, Brazil · Concepción, Chile

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

Acute Kidney Injury · Chronic Kidney Diseases · Solid-organ Transplantation

Abroad (travel likely)Recruiting

Toulouse, France

Renal Resistive Index as a Predictor of Acute Renal Impairment in High-risk Patients

Acute Kidney Injury · Critical Illness

Abroad (travel likely)Recruiting

Aswān, Egypt